23andMe Directors Resign
Amgen's immunology drug results —The Novo Nordisk Senate hearing —Sanofi's soul-searching Read on to learn more.
SUNNYVALE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co., (Nasdaq: ME), a leading human genetics and preventive health ...
Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...
On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...
4don MSN
The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...
Business Insider on MSN6d
Read the memo 23andMe's cofounder sent to staff after the entire board quitMe's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.
The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...
Me Holding Co., (NASDAQ: ME) shares squeaked ahead mid-week Wednesday. The company, a leading human genetics and preventive health concern, today released a new report on the genetics of emotional ...
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback